{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:21:36Z","timestamp":1790968896703,"version":"4.1.0"},"reference-count":23,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2007,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            CTX-M-type extended-spectrum \u03b2-lactamases (ESBLs) have become increasingly common worldwide, with the notable exception of the United States, where TEM- and SHV-type ESBLs have appeared to predominate. We have noted the emergence of ESBLs in our health care system (the University Health System in San Antonio, TX), especially in\n            <jats:italic>Escherichia coli<\/jats:italic>\n            isolates, that preferentially hydrolyze cefotaxime rather than ceftazidime, suggesting the possibility of CTX-M-type enzymes. Microbiology laboratory records were reviewed to identify ESBL-producing isolates and to compare the diameters of ceftazidime disk diffusion zones of inhibition to cefotaxime zone diameters. All isolates had been initially detected and confirmed using the procedures recommended by the Clinical and Laboratory Standards Institute. A total of 94 stored ESBL-producing isolates recovered between January 2000 and June 2006 (predominately from blood and normally sterile fluids) were retrieved for further study and screened using PCR primers specific for the presence of CTX-M, TEM, and SHV ESBLs. Only small numbers of retained ESBL-producing isolates were available for study in 2000 and 2002. The percentages of available ESBL-producing organisms in the following years were found to produce CTX-M enzymes: 2000, 25%; 2001, 10%; 2002, 0%; 2003, 60%; 2004, 69%; 2005, 89%; and 2006, 70%. The most common CTX-M-type ESBL was CTX-M-15, followed by CTX-M-16, CTX-M-8, and CTX-M-14. Comparing the disk diffusion zone diameters of cefotaxime and ceftazidime was helpful with the initial recognition of CTX-M-producing\n            <jats:italic>E. coli<\/jats:italic>\n            , which had an average cefotaxime zone diameter 7 mm smaller than the ceftazidime zone. However, comparing ceftazidime and cefotaxime zones for CTX-M-producing\n            <jats:italic>Klebsiella<\/jats:italic>\n            spp. was not helpful with initial recognition. CTX-M enzymes were also identified in\n            <jats:italic>Proteus mirabilis<\/jats:italic>\n            ,\n            <jats:italic>Enterobacter<\/jats:italic>\n            spp., and\n            <jats:italic>Morganella morganii<\/jats:italic>\n            . Based on pulsed-field gel electrophoresis typing of the\n            <jats:italic>E. coli<\/jats:italic>\n            isolates, the CTX-M-producing isolates did not represent the spread of a single clone in the institution or in the community. In conclusion, CTX-M-type ESBLs are now the most common ESBL type isolated from patients in our health care system and may also be present but unrecognized in other U.S. locales.\n          <\/jats:p>","DOI":"10.1128\/aac.00576-07","type":"journal-article","created":{"date-parts":[[2007,8,28]],"date-time":"2007-08-28T00:29:11Z","timestamp":1188260951000},"page":"4015-4021","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":182,"title":["First Report of the Emergence of CTX-M-Type Extended-Spectrum \u03b2-Lactamases (ESBLs) as the Predominant ESBL Isolated in a U.S. Health Care System"],"prefix":"10.1128","volume":"51","author":[{"suffix":"II","given":"James S.","family":"Lewis","sequence":"first","affiliation":[{"name":"Department of Pharmacy, University Health System, San Antonio, Texas"},{"name":"Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Herrera","sequence":"additional","affiliation":[{"name":"Departments of Microbiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Wickes","sequence":"additional","affiliation":[{"name":"Departments of Microbiology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan E.","family":"Patterson","sequence":"additional","affiliation":[{"name":"Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James H.","family":"Jorgensen","sequence":"additional","affiliation":[{"name":"Departments of Microbiology"},{"name":"Medicine"},{"name":"Pathology, University of Texas Health Science Center, San Antonio, Texas 78229"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/500936"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.1.1-14.2004"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/512370"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.23.12.1232.32706"},{"key":"e_1_3_2_6_2","unstructured":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 2007"},{"key":"e_1_3_2_7_2","unstructured":"Performance standards for antimicrobial disk susceptibility tests. 2007"},{"key":"e_1_3_2_8_2","unstructured":"Performance standards for antimicrobial susceptibility testing. 2007"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.12.3724-3732.2003"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/508891"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl483"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/505598"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2005.11.31"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.34.12.3138-3141.1996"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.7.2382-2383.2003"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh397"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.11.3554-3560.2003"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-1-200401060-00008"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1086\/420816"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.12.5715-5721.2004"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01377-06"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1086\/508877"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/500945"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.44.8.2034-2038.2000"}],"updated-by":[{"DOI":"10.1128\/aac.01501-07","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000}}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00576-07","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.00576-07","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T19:15:46Z","timestamp":1645470946000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.00576-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["10.1128\/AAC.00576-07"],"URL":"https:\/\/doi.org\/10.1128\/aac.00576-07","relation":{"correction":[{"id-type":"doi","id":"10.1128\/AAC.01501-07","asserted-by":"object"}]},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11]]},"assertion":[{"value":"2007-05-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-08-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2007-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}